Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Polish Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bushara, K. O.
Right arrow Articles by Exconde, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bushara, K. O.
Right arrow Articles by Exconde, R. E.
Related Collections
Right arrow Tremor
Right arrow All Clinical trials
Right arrow Clinical trials Randomized controlled (CONSORT agreement)
NEUROLOGY 2005;64:1078-1080
© 2005 American Academy of Neurology


Brief Communications

The effect of levetiracetam on essential tremor

Khalafalla O. Bushara, MD, Taimur Malik, MD and Rupert E. Exconde, MD

From the Neurology Service, Minneapolis Veterans Affairs Medical Center, MN.

Address correspondence and reprint requests to Dr. K. Bushara, Neurology Service (127), Minneapolis Veterans Affairs Medical Center, One Veterans Drive, Minneapolis, MN 55417; e-mail: busha001{at}umn.edu

The effect of a single dose of 1,000 mg of levetiracetam on essential tremor was investigated in 24 patients in a double-blind, placebo-controlled trial. There was a significant reduction of hand tremor for at least 2 hours as measured by accelerometry and functional tests.


Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the March 22 issue to find the link for this article.

Supported by the Department of Veterans Affairs and an investigator-initiated study grant from UCB-Pharma. K.O.B. and R.E.E. have received honoraria from UCB-Pharma.

Received January 6, 2004. Accepted in final form November 23, 2004.




This article has been cited by other articles:


Home page
Mult SclerHome page
P Feys, MB D'hooghe, G Nagels, and W. Helsen
The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis
Multiple Sclerosis, March 1, 2009; 15(3): 371 - 378.
[Abstract] [PDF]


Home page
BMJ Case ReportsHome page
P Striano, A. Elefante, A. Coppola, F. Tortora, F. Zara, and C. Minetti
Dramatic response to levetiracetam in post-ischaemic Holmes' tremor
BMJ Case Reports, January 22, 2009; 2009(jan21_1): bcr0820080643 - bcr0820080643.
[Abstract] [Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P. Striano, A. Elefante, A. Coppola, F. Tortora, F. Zara, C. Minetti, and S. Striano
Dramatic response to levetiracetam in post-ischaemic Holmes' tremor
J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 438 - 439.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.